Kristin D. Gerson, M.D., Ph.D.
Assistant Professor of Obstetrics and Gynecology
Active Physician, Maternal Fetal Medicine, Department of Gynecology, Penn Presbyterian Medical Center, Philadelphia, PA
Attending Physician, Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending Physician, Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Obstetrics and Gynecology
Graduate Group Affiliations
Contact information
Maternal Fetal Medicine
Hospital of the University of Pennsylvania
3400 Spruce Street, 2 Silverstein
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
3400 Spruce Street, 2 Silverstein
Philadelphia, PA 19104
Education:
B.A.
Stanford University, Palo Alto, CA, 2004.
MD
University of Massachusetts Medical School, Worcester, MA, 2014.
Ph.D. (Cancer Biology)
University of Massachusetts Medical School, Worcester, MA, 2014.
Permanent linkB.A.
Stanford University, Palo Alto, CA, 2004.
MD
University of Massachusetts Medical School, Worcester, MA, 2014.
Ph.D. (Cancer Biology)
University of Massachusetts Medical School, Worcester, MA, 2014.
Description of Research Expertise
Dr. Gerson is a Maternal Fetal Medicine physician scientist conducting fundamental and translational research in reproductive biology with a specific focus on microbiome-metabolome interactions governing cervical remodeling and preterm birth.Selected Publications
Ferguson B, Curry D, Friedman E, McCoy JA, Planet PJ, Flannery D, Puopolo K, Anton L, Gerson KD: Common vaginal microbes modify Group B Streptococcus growth at epithelial barriers: potential mechanisms governing colonization. Accepted as poster presentation at the Society for Maternal-Fetal Medicine’s 44th Annual Pregnancy Meeting Feb 2024.Ferguson B, Loder A, Gordon SM, Anton L, Gerson KD: Vaginal putrescine attenuates microbe-mediated inflammation in the cervical epithelium. Accepted as oral presentation in the Concurrent Session 1 - Prematurity at the Society for Maternal-Fetal Medicine’s 44th Annual Pregnancy Meeting Feb 2024.
Ferguson B, Loder A, Gordon SM, Anton L, Gerson KD: Vaginal polyamines mitigate inflammasome activation: potential immune mechanisms governing barrier function in preterm birth. Accepted as oral presentation in the Concurrent Session 1 - Prematurity at the Society for Maternal-Fetal Medicine’s 44th Annual Pregnancy Meeting Feb 2024.
Gerson KD, Loder A, Landau Z, Anton: Xenobiotic metabolites modify immune responses of the cervicovaginal epithelium: potential mechanisms underlying barrier disruption. BJOG 2023 Online ahead of print.
McCoy JA, Burris HH, Gerson KD, McCarthy C, Ravel J, Elovitz MA: Cervicovaginal Microbial-Immune State and Group B Streptococcus Colonization in Pregnancy. Am J Perinatol 2023 Online ahead of prin.
McCoy JA, Bromwich K, Gerson KD, Levine LD: Association between intrapartum antibiotic prophylaxis for Group B Streptococcus colonization and clinical chorioamnionitis among patients undergoing induction of labor at term. Am J Obstet Gynecol 229(6):672.e1-672.e8., Dec 2023.
Sanchez L, Escobar FA, Finn LS, Gerson KD, Janssen M, Acord MR: In utero torsion of an accessory hepatic lobe mimicking a congenital tumor. Pediatr Radiol 53(6):1211-1215, May 2023.
Gerson KD, Yang N, Landau Z, Ravel J, Elovitz ME, Burrus HH: Tyramine paradoxically suppresses immune output of the cervicovaginal epithelium: potential mechanisms promoting a Lactobacillus-deplete microbiota. Poster presentation at the Society for Maternal-Fetal Medicine’s 43rd Annual Pregnancy Meeting, San Francisco, CA Feb 2023.
Gerson KD, Landau Z, Anton L, Elovitz ME: Xenobiotic metabolites modify immune output of the cervicovaginal epithelium: potential mechanisms underlying barrier disruption. Oral presentation in the Opening Plenary of the Society for Maternal-Fetal Medicine’s 43rd Annual Pregnancy Meeting, San Francisco, CA Feb 2023.
Gerson KD, Yang N, Ravel J, Elovitz ME, Burrus HH: Microbes common in a Lactobacillus-deplete microbiota are negatively correlated with lipid metabolite abundance in pregnancy. Poster presentation at the Society for Maternal-Fetal Medicine’s 43rd Annual Pregnancy Meeting, San Francisco, CA Feb 2023.